FATMATA KOROMA: Open Payments
NPI 1518685106 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$256 in 3 payments from 3 companies in 2025. Trend: 2023 $120 · 2024 $495 · 2025 $256
Food & beverage: $256
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 1 | $115 |
| Luye Pharma (USA) Ltd. | 1 | $19 |
Products named: COBENFY, UZEDY, ERZOFRI EXTENDED-RELEASE.
Industry payments across NC — which companies pay providers there.
